Perspective

Nature Reviews Genetics 7, 72-76 (January 2006) | doi:10.1038/nrg1744

Science and societyHuman dignity: a guide to policy making in the biotechnology era?

Timothy Caulfield1 & Roger Brownsword2  About the authors

Top

This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.

Author affiliations

  1. Timothy Caulfield is at the Faculty of Law and the Faculty of Medicine and Dentistry at the University of Alberta, Edmonton, Alberta T6G 2H5, Canada.
  2. Roger Brownsword is at the School of Law, King's College London, Strand, London WC2R 2LS, UK.

Correspondence to: Timothy Caulfield1 Email: tcaulfld@law.ualberta.ca

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

RESEARCH

Potential harms, anonymization, and the right to withdraw consent to biobank research

European Journal of Human Genetics Article Response

Extra navigation

Subscribe

Subscribe to Nature Reviews Genetics

Search PubMed for

naturejobs

natureproducts


Advertisement